JENDZELOVSKY, Rastislav, Jaromir MIKES, Jan KOVAL, Karel SOUČEK, Jiřina PROCHÁZKOVÁ, Martin KELLO, Veronika SACKOVA, Jiřina HOFMANOVÁ, Alois KOZUBÍK and Peter FEDOROČKO. Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES. 2009, vol. 8, No 12, 8 pp. ISSN 1474-905X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells
Authors JENDZELOVSKY, Rastislav (703 Slovakia), Jaromir MIKES (703 Slovakia), Jan KOVAL (703 Slovakia), Karel SOUČEK (203 Czech Republic), Jiřina PROCHÁZKOVÁ (203 Czech Republic), Martin KELLO (703 Slovakia), Veronika SACKOVA (703 Slovakia), Jiřina HOFMANOVÁ (203 Czech Republic), Alois KOZUBÍK (203 Czech Republic, guarantor) and Peter FEDOROČKO (703 Slovakia).
Edition PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2009, 1474-905X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.708
RIV identification code RIV/00216224:14310/09:00039943
Organization unit Faculty of Science
UT WoS 000272142300010
Keywords in English MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; JOHNS-WORT; MXR ABCG2; METABOLISM; TOXICITY; INHIBITORS; INDUCTION; MODULATION; EXPRESSION
Tags International impact, Reviewed
Changed by Changed by: Mgr. Jiřina Medalová, Ph.D., učo 176525. Changed: 9/4/2010 14:02.
Abstract
Photodynamic therapy (PDT) is a flexible multi-target therapeutic approach. Mechanisms of anticancer drug elimination by tumour cells are mostly linked to the elevated expression and activity of P-glycoprotein (P-gp), multidrug resistance-associated protein 1 (MRP1), breast cancer resistance protein (BCRP) and P450 monooxygenases. We report here for the first time increased activity of MRP1 and BCRP in HT-29 colon cancer cells treated with hypericin per se. On the contrary, pre-treatment with proadifen (SKF525A) affected the function of MRP1 and BCRP leading to increased hypericin content, which might indicate a possible link between proadifen and these ABC transporter proteins. Subsequent enhanced intracellular oxidative stress was accompanied by loss of mitochondrial membrane potential, activation of caspase-9 and -3, PARP cleavage and onset of apoptosis.
PrintDisplayed: 1/5/2024 18:42